Pharmaceutical Industry, Academia, Regulatory Authorities and End User Collaboration in Successful Drug Discovery and Development
No Thumbnail Available
Date
2021-02-18T00:00:00
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Singapore
Abstract
This chapter reviews the literature on the various factors (time-consuming processes, regulatory requirements, high attrition rate in phase III clinical trials and decrease in RandD productivity) contributed to increase the average cost of drug discovery. A better interaction between the stakeholders, i.e. pharmaceutical industry, academia, regulatory authorities and end users, results in efficacious, safe and affordable drugs to the benefit of the society. � Springer Nature Singapore Pte Ltd. 2021.
Description
Keywords
Academia, Patients, Pharmaceutical Industry, Regulatory Authorities, Translational Research